Treatment of bipolar disorders and associated symptoms

Details for Australian Patent Application No. 2005293552 (hide)

Owner N.V. Organon

Inventors Wong, Erik Ho Fong; Schipper, Jacques; Panagides, John

Agent Spruson & Ferguson

Pub. Number AU-B-2005293552

PCT Pub. Number WO2006/040314

Priority 60/619,274 15.10.04 US; 60/620,178 19.10.04 US

Filing date 11 October 2005

Wipo publication date 20 April 2006

Acceptance publication date 14 April 2011

International Classifications

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

Event Publications

3 May 2007 PCT application entered the National Phase

  PCT publication WO2006/040314 Priority application(s): WO2006/040314

12 July 2007 Assignment before Grant

  Pfizer Inc.; N.V. Organon The application has been assigned to N.V. Organon 2006

14 April 2011 Application Accepted

  Published as AU-B-2005293552

11 August 2011 Standard Patent Sealed

22 December 2011 Alteration of Name

  The name of the patentee has been altered to MSD Oss B.V.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005293553-Geodesic position determining system

2005293529-Synthetic peptides which reduce or eliminate bags formed under the lower rim of the eyes and use thereof in cosmetic or dermopharmaceutical compositions